300 related articles for article (PubMed ID: 19796752)
1. Molecular predictive and prognostic markers in non-small-cell lung cancer.
Coate LE; John T; Tsao MS; Shepherd FA
Lancet Oncol; 2009 Oct; 10(10):1001-10. PubMed ID: 19796752
[TBL] [Abstract][Full Text] [Related]
2. Predictive markers in the adjuvant therapy of non-small cell lung cancer.
Filipits M; Pirker R
Lung Cancer; 2011 Dec; 74(3):355-63. PubMed ID: 21885151
[TBL] [Abstract][Full Text] [Related]
3. Tissue sampling in lung cancer: a review in light of the MERIT experience.
Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: a review of published data.
Mountzios G; Dimopoulos MA; Soria JC; Sanoudou D; Papadimitriou CA
Crit Rev Oncol Hematol; 2010 Aug; 75(2):94-109. PubMed ID: 19914087
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers, prediction, and prognosis in non-small-cell lung cancer: a platform for personalized treatment.
Sudhindra A; Ochoa R; Santos ES
Clin Lung Cancer; 2011 Nov; 12(6):360-8. PubMed ID: 21729648
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer.
Sterlacci W; Fiegl M; Tzankov A
Pathobiology; 2012; 79(4):175-94. PubMed ID: 22441109
[TBL] [Abstract][Full Text] [Related]
7. Prognostic immune markers in non-small cell lung cancer.
Suzuki K; Kachala SS; Kadota K; Shen R; Mo Q; Beer DG; Rusch VW; Travis WD; Adusumilli PS
Clin Cancer Res; 2011 Aug; 17(16):5247-56. PubMed ID: 21659461
[TBL] [Abstract][Full Text] [Related]
8. "Personalizing" therapy for non-small cell lung cancer.
D'Cunha J
Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
[TBL] [Abstract][Full Text] [Related]
9. Molecular predictors of response to chemotherapy in non-small cell lung cancer.
Andrews J; Yeh P; Pao W; Horn L
Cancer J; 2011; 17(2):104-13. PubMed ID: 21427554
[TBL] [Abstract][Full Text] [Related]
10. Strategies for improving outcomes in NSCLC: a look to the future.
Stahel R; Peters S; Baas P; Brambilla E; Cappuzzo F; De Ruysscher D; Eberhardt WE; Felip E; Fennell D; Marchetti A; Paz-Ares L; Adjei AA
Lung Cancer; 2013 Dec; 82(3):375-82. PubMed ID: 24094287
[TBL] [Abstract][Full Text] [Related]
11. The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.
Sève P; Reiman T; Dumontet C
Lung Cancer; 2010 Feb; 67(2):136-43. PubMed ID: 19828208
[TBL] [Abstract][Full Text] [Related]
12. Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomics.
Harpole DH
Thorac Surg Clin; 2007 May; 17(2):167-73, viii. PubMed ID: 17626395
[TBL] [Abstract][Full Text] [Related]
13. New agents in advanced non-small-cell lung cancer treatment.
Ricciardi S; de Marinis F
Oncology; 2009; 77 Suppl 1():103-12. PubMed ID: 20130438
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in non-small cell lung carcinoma.
Koutsami MK; Gorgoulis VG; Kastrinakis NG; Asimacopoulos PJ; Kittas C
Anticancer Res; 2002; 22(1A):347-74. PubMed ID: 12017316
[TBL] [Abstract][Full Text] [Related]
16. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
Vilmar A; Sørensen JB
Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
[TBL] [Abstract][Full Text] [Related]
17. The role of prognostic factors and oncogenes in the detection and management of non-small-cell lung cancer.
Van Zandwijk N; Van 't Veer LJ
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):55-9. PubMed ID: 9516613
[TBL] [Abstract][Full Text] [Related]
18. [Is lung cancer in women different?].
Ben Aissa A; Mach N
Rev Med Suisse; 2012 May; 8(342):1108-11. PubMed ID: 22734179
[TBL] [Abstract][Full Text] [Related]
19. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
20. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
Rossi G; Graziano P; Leone A; Migaldi M; Califano R
Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
